On October 14, 2026, Allswell, a San Francisco-based virtual behavioral-health company built for LGBTQ+ patients, announced a $7 million seed round led by Rethink Impact. Magnify Ventures, Ulu Ventures and Hopelab Ventures joined, alongside existing investors Techstars and Amboy Street Ventures. Together with a $1.3 million pre-seed led by Amboy Street, total funding is now $8.3 million. Allswell offers one-on-one virtual therapy, group programs and trauma-informed care, and it is paid for by commercial insurance and Medicaid rather than out of pocket.

Why It Matters

The deal follows the playbook that turned menopause into a venture category: pick a group the healthcare system serves badly, get in-network with insurers, keep patients for the long term, then add services. Investors are applying the same model to LGBTQ+ health from several directions. Grindr bought PrEP provider Freddie for $250M and launched "Grindr Health," MISTR has built a free sexual-health stack, and now Allswell is starting from mental health. Sexual-health and identity-specific care sit next to each other in this market, and a behavioral-health "medical home" that later adds medication management is a natural channel for PrEP, hormone and sexual-function care. A seed round led by Rethink, best known as a female-founder fund, also signals that the investors who backed femtech see LGBTQ+ health as the next underserved category.

Allswell launched in spring 2025 and so far treats patients only in Washington, D.C., Maryland and Virginia. The company says it sees "hundreds of active patients" and bills more than 1,500 sessions a month. CEO and co-founder Dawn Androphy told Behavioral Health Business that about 40 clinicians work on the platform, many of them recently graduated, supervised therapists who complete Allswell's own LGBTQ+-specific clinical training. The new money goes to geographic expansion, that training program and psychiatric medication management next year, the first step toward what the company calls a full "medical home" for LGBTQ+ patients. Allswell says many patients stay longer than a year, against an industry norm of six to eight sessions, and that this makes revenue per patient "3–9x the industry norm." That figure is the company's own and unaudited.

Rethink Impact managing partner Heidi Patel described the bet in femtech terms: "Only 5% of Gen X identifies as LGBTQ+, compared with 25% of Gen Z... we want to do for LGBTQ+ health what Midi did for menopause." In the release, the company also says half of medical students receive no LGBTQ+-care training and 80% of healthcare professionals say they don't feel competent treating LGBTQ+ patients.

Sources

Update — 2026-10-17

Initial entry — story first created.